Corona Remedies moves up as company secures EAEU-GMP certification for global expansionCorona Remedies moves up as company secures EAEU-GMP certification for global expansion

Introduction

Leading pharmaceutical manufacturer secures EAEU-GMP certification for its Bhayla facility, enabling exports to five Eurasian nations and strengthening its presence across global pharmaceutical markets.

Also Read: Zaggle secures 10-year contract with Forever New Apparels under employee purchase programme

Share price movement of Corona Remedies

On January 22, 2026, Corona Remedies Ltd opened at ₹1,402.00, up 1.07% from its previous close of ₹1,387.30. The stock reached a high of ₹1,415.05 (2.01%) and a low of ₹1,386.95. By 3:08 PM, it traded at ₹1,396.30, a 0.65% increase, with a market cap of ₹8,539.78 crore.

Corona Remedies Receives EAEU–GMP Certification

Corona Remedies Limited has received EAEU-GMP certification for its finished dosage facility in Bhayla, Gujarat. This accreditation allows the company to export medicines to five EAEU member nations.

The certification enables access to a pharmaceutical market worth USD 25 billion. CORONA will operate under a B2B business model across Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan.

Corona Remedies focuses on four therapeutic areas: Women’s Health, Cardio-Diabetes, Pain Management, and Urology. The certification highlights the company’s quality systems and compliance with global manufacturing standards.

Stock performance of Corona Remedies for Period of 1 week and 1 month

Corona Remedies Ltd fell 5.89% over the past week and gained 1.89% over the past one month.

Also Read: This penny stock joins hands with Rajasthan Financial Services for digital lending initiative; do you own it?

Shareholding pattern of Corona Remedies

Particulars	Dec 2025
Promoter	69.00%
FII	1.80%
DII	6.80%
Public	22.40%

About Corona Remedies

Corona Remedies Limited (NSE: CORONA) is a branded pharmaceutical company in India, focusing on women’s healthcare, cardio-diabetes, pain management, urology, and delivering high-quality accessible medicines nationwide.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs